Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate is used in the preparation of phenylpyrazinoylguanidines as sodium channel blockers possessing β-agonist activity. These compounds are useful for promoting hydration of mucosal surfaces and treating a variety of disease conditions.
參考文獻
Johnson, M.R.; et al.: U.S. No pp. given Patent 2012 CODEN:USXXAM
滬ICP備17019645號
400-821-0725
